By Editor , 14 October 2026
Clinical ink Targets 67% Obesity Drug Drop-Off With Behavioral Data

Toronto – October 14, 2026 -- Real-world discontinuation of weight-loss medications can reach 67% within 12 months, while clinical trials show sustained weight reduction of 15–22% over 72 weeks, according to materials for an Xtalks webinar featuring Clinical ink executives on October 29.

By Editor , 14 October 2026
Deloitte to Demo AI Adverse Event Intake in Oct. 28 Webinar

Toronto – October 14, 2026 -- Deloitte Consulting LLP will demonstrate live how AI-enabled case intake can handle incoming adverse event data in pharmacovigilance during an Xtalks webinar on Wednesday, October 28, 2026, at 1pm EDT (10am PDT).